{"schema_version":"secwatch.filing_event.v1","accession":"0001599298-24-000040","form_type":"8-K","ticker":"SMMT","cik":"0001599298","company_name":"Summit Therapeutics Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.759657+00:00","generated_at":"2026-06-04T23:01:45.726393+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Summit Therapeutics presents at Barclays conference; no new material disclosed in filing excerpt","bullets":["Presentation slides made available on March 12, 2024 at Barclays Global Healthcare Conference.","Speakers listed: Dr. Maky Zanganeh (CEO & President) and Bob Duggan (Chairman & CEO).","No specific pipeline updates, financial data, or clinical results provided in the filed exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001599298-24-000040","json":"https://secwatch.observer/filing/0001599298-24-000040.json","markdown":"https://secwatch.observer/filing/0001599298-24-000040.md","text":"https://secwatch.observer/filing/0001599298-24-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000040/0001599298-24-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000040/smmt-20240312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:01:45.726393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}